{
    "profile_id": "tomdenee",
    "first_name": "Tom",
    "last_name": "Denee",
    "sub_title": "Compound Market Access Leader Europe Middle East & Africa (EMEA) at Janssen EMEA",
    "profile_picture": "https://media.licdn.com/dms/image/C5603AQHFRwBhpSdEcg/profile-displayphoto-shrink_400_400/0/1517698490569?e=1701302400&v=beta&t=ueNukeapaN2tOCJvcA2mu0xDuVJk-5ZdD2BH2KCeo4I",
    "background_image": null,
    "profile_type": "personal",
    "entity_urn": "ACoAAAIRqj8BeeKYv7LLmp3FMWA8nO6EL1fPtVk",
    "object_urn": 34712127,
    "birth_date": null,
    "summary": "Goal-oriented health economics, access and Real World Evidence (RWE) people leader with broad experience in the pharmaceutical industry at Global, European, UK and Dutch level, with strong analytical and research skills, a positive mindset and social capabilities with ambitions for a senior strategic leadership role.\n\n- From March 2021 onwards, working as Compound Market Access Lead Europe, Middle East and Africa (EMEA) to ensure that the right patients have timely access to gene therapies in the retina disease area\n- February 2018 - February 2021, worked as Senior Manager Health Economics, Market Access and Reimbursement at Janssen in UK leading a team of health economists working to enable access to new innovations in the field of neuroscience and infectious diseases (vaccines) \n- Took on additional role as cross-functional team-lead for vaccines since June 2020 onwards\n- 2017: worked within the European, Middle East and African region (EMEA) Market Access Team for neuroscience (dual citizenship)\n- 2017: president of the Young Innovators of Medicines (younger department of Dutch association of pharmaceutical companies)\n- From 2014 - February 2018, worked as Manager Health Economics, Market Access and Reimbursement at Janssen Netherlands in infectious diseases, neurosciences, hematology and oncology \n- 2014: did stretch assignment (2 days a week) for Janssen Global Health Economics, Market Access and Reimbursement Team in infectious diseases (hepatitis C)\n- Worked fulltime as Global Business Manager Marketed Products as well as Global Product Team Lead for Dukoral (cholera vaccines) from January 2012 until October 2014 for Crucell, affiliate of Johnson & Johnson at Crucell's HQ, Leiden, The Netherlands\n- Worked fulltime as Junior Manager at Business Management department (mix of business development and strategic marketing) of Crucell's paediatric franchise, from November 2010 - January 2012 at Crucell's HQ, Leiden, The Netherlands\n- Worked as a pharmacist, from August 2008 - October 2010 at Apotheek Koert, Utrecht, The Netherlands\n\n- MSc Business Administration at Rotterdam School of Management. Graduated cum laude (with distinction) in September 2010\n- MSc in Pharmaceutical Sciences at University of Utrecht\n- NIMA-A course at NHA\n- Work experience for almost 10 years in different pharmacies with various functions, \n\nSpecialties: \n- (Inter-)national Market Access\n- Health Economics\n- Reimbursement and negotiations\n- Real World Evidence\n- Marketing (strategic and managing)\n- Access policy shaping\n- M&A experience",
    "location": {
        "country": "Netherlands",
        "short": "Zeist, Utrecht",
        "city": "Zeist",
        "state": "Utrecht",
        "default": "Zeist, Utrecht, Netherlands"
    },
    "premium": false,
    "influencer": false,
    "treasury_media": [],
    "languages": {
        "primary_locale": {
            "country": "US",
            "language": "en"
        },
        "supported_locales": [
            {
                "country": "US",
                "language": "en"
            }
        ],
        "profile_languages": [
            {
                "name": "Dutch",
                "proficiency": "NATIVE_OR_BILINGUAL"
            },
            {
                "name": "English",
                "proficiency": "FULL_PROFESSIONAL"
            },
            {
                "name": "German",
                "proficiency": "LIMITED_WORKING"
            }
        ]
    },
    "industry": "Pharmaceuticals",
    "education": [
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2008
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2010
                }
            },
            "school": {
                "name": "Rotterdam School of Management, Erasmus University",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQGxI95CurHtdA/company-logo_400_400/0/1657183585379/rotterdam_school_of_management_erasmus_university_logo?e=1703721600&v=beta&t=7toMl2LFJL12H2mV0JQWRclssYvPW9IyOKbrDKU0Pg0",
                "url": "https://www.linkedin.com/school/rotterdam-school-of-management-erasmus-university/"
            },
            "degree_name": "MScBA",
            "field_of_study": "General Management",
            "grade": "MSc"
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2004
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2008
                }
            },
            "school": {
                "name": "Utrecht University",
                "logo": "https://media.licdn.com/dms/image/C510BAQG6HfmPTdJKXw/company-logo_400_400/0/1519884681258?e=1703721600&v=beta&t=dip0JQLPHIafltY09rUwsjeZiPiJpmfD6vJeMHxW-84",
                "url": "https://www.linkedin.com/school/universiteit-utrecht/"
            },
            "degree_name": "MSc",
            "field_of_study": "Pharmaceutical Sciences",
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2001
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2004
                }
            },
            "school": {
                "name": "Utrecht University",
                "logo": "https://media.licdn.com/dms/image/C510BAQG6HfmPTdJKXw/company-logo_400_400/0/1519884681258?e=1703721600&v=beta&t=dip0JQLPHIafltY09rUwsjeZiPiJpmfD6vJeMHxW-84",
                "url": "https://www.linkedin.com/school/universiteit-utrecht/"
            },
            "degree_name": "BSc",
            "field_of_study": "Pharmaceutical Sciences",
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 1995
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2001
                }
            },
            "school": {
                "name": "CC Groevenbeek",
                "logo": null,
                "url": null
            },
            "degree_name": "VWO",
            "field_of_study": "English, Dutch, Physics, Biology, Mathemathics A and B, Geography, Chemistry",
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": null
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "school": {
                "name": "ISPOR",
                "logo": null,
                "url": null
            },
            "degree_name": null,
            "field_of_study": null,
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": null
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "school": {
                "name": "ISPOR",
                "logo": null,
                "url": null
            },
            "degree_name": null,
            "field_of_study": null,
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": null
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "school": {
                "name": "ISPOR",
                "logo": null,
                "url": null
            },
            "degree_name": null,
            "field_of_study": null,
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": null
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "school": {
                "name": "Primary school",
                "logo": null,
                "url": null
            },
            "degree_name": null,
            "field_of_study": null,
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": null
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "school": {
                "name": "SIR Pharma",
                "logo": null,
                "url": null
            },
            "degree_name": null,
            "field_of_study": null,
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": null
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "school": {
                "name": "SIR Pharma",
                "logo": null,
                "url": null
            },
            "degree_name": null,
            "field_of_study": null,
            "grade": null
        }
    ],
    "patents": [],
    "awards": [],
    "certifications": [],
    "organizations": [],
    "projects": [],
    "publications": [
        {
            "name": "The lived experience of major and treatment-resistant depression in England: a mixed-methods study",
            "publisher": "Acta Psychologica",
            "url": "https://www.sciencedirect.com/science/article/pii/S0001691823002111",
            "date": {
                "month": null,
                "day": null,
                "year": 2023
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Tom",
                    "last_name": "Denee",
                    "name": null,
                    "headline": "Compound Market Access Leader Europe Middle East & Africa (EMEA) at Janssen EMEA"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Cicely",
                    "last_name": "Kerr",
                    "name": null,
                    "headline": "Bringing together different perspectives to explore and evidence issues that affect people's lives"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Sally-Anne",
                    "last_name": "Vincent",
                    "name": null,
                    "headline": "Senior Consultant at Vitaccess || Patient Centred Outcomes || Real-World Evidence"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Karen",
                    "last_name": "Bailey, PhD",
                    "name": null,
                    "headline": "Qualitative and mixed methods researcher, exit/embedded interviews"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Shanaya",
                    "last_name": "Rathod",
                    "name": null,
                    "headline": "Visiting Professor at University of Portsmouth"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Mitesh R",
                    "last_name": "Desai  BA(Hons), MB.ChB, MBA",
                    "name": null,
                    "headline": "Intensive Care | COVID-19 | Medical Affairs | Market Access | Medical Journalism"
                }
            ]
        },
        {
            "name": "The impact of treatment-resistant depression on the lives of carers: A mixed-methods study",
            "publisher": "Journal of Affective Disorders",
            "url": "https://www.sciencedirect.com/science/article/pii/S0165032722014975?dgcid=author",
            "date": {
                "month": null,
                "day": null,
                "year": 2022
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Tom",
                    "last_name": "Denee",
                    "name": null,
                    "headline": "Compound Market Access Leader Europe Middle East & Africa (EMEA) at Janssen EMEA"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Cicely",
                    "last_name": "Kerr",
                    "name": null,
                    "headline": "Bringing together different perspectives to explore and evidence issues that affect people's lives"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Joe",
                    "last_name": "Eva",
                    "name": null,
                    "headline": "Data Analyst at CGA Experience"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Sally-Anne",
                    "last_name": "Vincent",
                    "name": null,
                    "headline": "Senior Consultant at Vitaccess || Patient Centred Outcomes || Real-World Evidence"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Allan Young",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Nicholas Jacobsen",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Mitesh R",
                    "last_name": "Desai  BA(Hons), MB.ChB, MBA",
                    "name": null,
                    "headline": "Intensive Care | COVID-19 | Medical Affairs | Market Access | Medical Journalism"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Laura Baldock",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Shanaya",
                    "last_name": "Rathod",
                    "name": null,
                    "headline": "Visiting Professor at University of Portsmouth"
                }
            ]
        },
        {
            "name": "Health-related quality of life burden associated with treatment-resistant depression in UK patients: Quantitative results from a mixed-methods non-interventional study",
            "publisher": "Journal of Affective Disorders",
            "url": "https://www.sciencedirect.com/science/article/abs/pii/S0165032721014087",
            "date": {
                "month": null,
                "day": null,
                "year": 2021
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Tom",
                    "last_name": "Denee",
                    "name": null,
                    "headline": "Compound Market Access Leader Europe Middle East & Africa (EMEA) at Janssen EMEA"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Shanaya",
                    "last_name": "Rathod",
                    "name": null,
                    "headline": "Visiting Professor at University of Portsmouth"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Cicely",
                    "last_name": "Kerr",
                    "name": null,
                    "headline": "Bringing together different perspectives to explore and evidence issues that affect people's lives"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Mitesh R",
                    "last_name": "Desai  BA(Hons), MB.ChB, MBA",
                    "name": null,
                    "headline": "Intensive Care | COVID-19 | Medical Affairs | Market Access | Medical Journalism"
                }
            ]
        },
        {
            "name": "Incidence of suicidality in people with depression over a 10-year period treated by a large UK mental health service provider",
            "publisher": "BJPsych Open",
            "url": "https://www.cambridge.org/core/journals/bjpsych-open/article/incidence-of-suicidality-in-people-with-depression-over-a-10year-period-treated-by-a-large-uk-mental-health-service-provider/68ADF89E00E729D8F2CEE608DFB9D021",
            "date": {
                "month": null,
                "day": null,
                "year": 2021
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Tom",
                    "last_name": "Denee",
                    "name": null,
                    "headline": "Compound Market Access Leader Europe Middle East & Africa (EMEA) at Janssen EMEA"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Cicely",
                    "last_name": "Kerr",
                    "name": null,
                    "headline": "Bringing together different perspectives to explore and evidence issues that affect people's lives"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Mitesh R",
                    "last_name": "Desai  BA(Hons), MB.ChB, MBA",
                    "name": null,
                    "headline": "Intensive Care | COVID-19 | Medical Affairs | Market Access | Medical Journalism"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Dr Gemma",
                    "last_name": "Scott",
                    "name": null,
                    "headline": "MBCHB, BA (Oxon), MA (Oxon), MRCP, PG Cert HBE "
                }
            ]
        },
        {
            "name": "Current treatments used in clinical practice for major depressive disorder and treatment resistant depression in England: A retrospective database study",
            "publisher": "Journal of Psychiatric Research",
            "url": "https://www.sciencedirect.com/science/article/abs/pii/S0022395621002958?CMX_ID=&SIS_ID=&dgcid=STMJ_AUTH_SERV_PUBLISHED&utm_acid=105717633&utm_campaign=STMJ_AUTH_SERV_PUBLISHED&utm_in=DM152787&utm_medium=email&utm_source=AC_",
            "date": {
                "month": null,
                "day": null,
                "year": 2021
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Tom",
                    "last_name": "Denee",
                    "name": null,
                    "headline": "Compound Market Access Leader Europe Middle East & Africa (EMEA) at Janssen EMEA"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Cicely",
                    "last_name": "Kerr",
                    "name": null,
                    "headline": "Bringing together different perspectives to explore and evidence issues that affect people's lives"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Timothy",
                    "last_name": "Ming",
                    "name": null,
                    "headline": "Health Economics & Market Access at Janssen Europe, Middle East & Africa (EMEA)"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Robert Wood",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Theo Tritton",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Chloe",
                    "last_name": "Middleton-Dalby",
                    "name": null,
                    "headline": "Statistics | Data Analytics | Real World Evidence"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Olivia Massey",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Mitesh R",
                    "last_name": "Desai  BA(Hons), MB.ChB, MBA",
                    "name": null,
                    "headline": "Intensive Care | COVID-19 | Medical Affairs | Market Access | Medical Journalism"
                }
            ]
        },
        {
            "name": "A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom",
            "publisher": "Current Medical Research and Opinion",
            "url": "https://www.tandfonline.com/doi/full/10.1080/03007995.2020.1857580",
            "date": {
                "month": null,
                "day": null,
                "year": 2020
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Tom",
                    "last_name": "Denee",
                    "name": null,
                    "headline": "Compound Market Access Leader Europe Middle East & Africa (EMEA) at Janssen EMEA"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Timothy",
                    "last_name": "Ming",
                    "name": null,
                    "headline": "Health Economics & Market Access at Janssen Europe, Middle East & Africa (EMEA)"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Tom Bailey",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Olivera Rajkovic-Hooley",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Chloe Middleton-Dalby",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Hoa H",
                    "last_name": "Le",
                    "name": null,
                    "headline": "Associate Director | Real World Value and Evidence | The Janssen Pharmaceutical Companies of Johnson & Johnson"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Qiaoyi Zhang",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Paul McCrone",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "David Taylor",
                    "headline": null
                }
            ]
        },
        {
            "name": "The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study",
            "publisher": "BMC Psychiatry",
            "url": "https://link.springer.com/epdf/10.1186/s12888-019-2222-4?author_access_token=gLAnYWRct8fXKOZQittST2_BpE1tBhCbnbw3BuzI2ROZg1ZcZFeIsS96tHl8vm0yjr-Bn5ZNhTq3tVafbIGouODLJAAhYD9MohofkSdVT2qsCklrd7QhKUv-xHcRGE9usPsB6qAvFVG195LgzHMbIg%3D%3D",
            "date": {
                "month": null,
                "day": null,
                "year": 2019
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Tom",
                    "last_name": "Denee",
                    "name": null,
                    "headline": "Compound Market Access Leader Europe Middle East & Africa (EMEA) at Janssen EMEA"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Dena",
                    "last_name": "Jaffe Hirschfield",
                    "name": null,
                    "headline": "Real-World Evidence & Data Strategist"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Beno\u00eet",
                    "last_name": "Rive",
                    "name": null,
                    "headline": "HEMAR EMEA Manager Analytics in Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson"
                }
            ]
        },
        {
            "name": "The burden of suicidal ideation across Europe: a cross-sectional survey in five countries",
            "publisher": "Neuropsychiatric Disease and Treatment",
            "url": "https://www.dovepress.com/articles.php?article_id=47696",
            "date": {
                "month": null,
                "day": null,
                "year": 2019
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Tom",
                    "last_name": "Denee",
                    "name": null,
                    "headline": "Compound Market Access Leader Europe Middle East & Africa (EMEA) at Janssen EMEA"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Beno\u00eet",
                    "last_name": "Rive",
                    "name": null,
                    "headline": "HEMAR EMEA Manager Analytics in Neuroscience at The Janssen Pharmaceutical Companies of Johnson & Johnson"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Dena",
                    "last_name": "Jaffe Hirschfield",
                    "name": null,
                    "headline": "Real-World Evidence & Data Strategist"
                }
            ]
        },
        {
            "name": "Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands",
            "publisher": "Journal of Medical Economics",
            "url": "http://dx.doi.org/10.1080/13696998.2017.1363050",
            "date": {
                "month": null,
                "day": null,
                "year": 2017
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Tom",
                    "last_name": "Denee",
                    "name": null,
                    "headline": "Compound Market Access Leader Europe Middle East & Africa (EMEA) at Janssen EMEA"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Fadi",
                    "last_name": "Tedouri",
                    "name": null,
                    "headline": "Associate Director, Global Pricing, Hematology at The Janssen Pharmaceutical Companies of Johnson & Johnson"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Kristel",
                    "last_name": "Van Impe",
                    "name": null,
                    "headline": "Healthcare Strategy"
                }
            ]
        },
        {
            "name": "Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study",
            "publisher": "PLOS ONE",
            "url": "http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0179049",
            "date": {
                "month": null,
                "day": null,
                "year": 2017
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Tom",
                    "last_name": "Denee",
                    "name": null,
                    "headline": "Compound Market Access Leader Europe Middle East & Africa (EMEA) at Janssen EMEA"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Flore",
                    "last_name": "Decuypere",
                    "name": null,
                    "headline": "Analytics lead EU immunology, Insights-to-Impact at UCB"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Jan",
                    "last_name": "Sermon",
                    "name": null,
                    "headline": "Compound Market Access Lead - Lung Cancer  at Janssen Europe, Middle East & Africa (EMEA)"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Paul",
                    "last_name": "Geerts",
                    "name": null,
                    "headline": "Retired at Janssen-Cilag BeNeLux"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Cedric",
                    "last_name": "De Vos",
                    "name": null,
                    "headline": "Associate Director Market Access  at Janssen Benelux"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Bart",
                    "last_name": "Malfait",
                    "name": null,
                    "headline": "Business Unit Director Respiratory & Immunology (BeLux) at AstraZeneca"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Niels",
                    "last_name": "Mulder",
                    "name": null,
                    "headline": "Professor in Psychiatry, Chairman Dutch Psychiatric Association"
                }
            ]
        },
        {
            "name": "Conceptual framework for outcomes research studies of hepatitis C: an analytical review",
            "publisher": "Infection and Drug Resistance",
            "url": "http://www.dovepress.com/articles.php?article_id=27181",
            "date": {
                "month": null,
                "day": null,
                "year": 2016
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Tom",
                    "last_name": "Denee",
                    "name": null,
                    "headline": "Compound Market Access Leader Europe Middle East & Africa (EMEA) at Janssen EMEA"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Urbano",
                    "last_name": "Sbarigia, PhD",
                    "name": null,
                    "headline": "Global Market Access Leader at Johnson & Johnson"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "George",
                    "last_name": "Wan, PhD, MPH",
                    "name": null,
                    "headline": "VP, Global Head of Evidence Generation & Data Sciences at Mallinckrodt Pharmaceuticals"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Gary Rice",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Norris Turner",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Geoffrey Dusheiko",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Alan Morrison",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Anna Kaufman",
                    "headline": null
                }
            ]
        },
        {
            "name": "Measuring the value of public\u2013private partnerships in the pharmaceutical sciences",
            "publisher": "Nature Reviews Drug Discovery",
            "url": "http://www.nature.com/nrd/journal/vaop/ncurrent/full/nrd3078-c1.html",
            "date": {
                "month": null,
                "day": null,
                "year": 2012
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Tom",
                    "last_name": "Denee",
                    "name": null,
                    "headline": "Compound Market Access Leader Europe Middle East & Africa (EMEA) at Janssen EMEA"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Arnold",
                    "last_name": "Sneekes",
                    "name": null,
                    "headline": "Co\u00f6rdinator Nationaal Groeifonds bij Rijksdienst voor Ondernemend Nederland (RVO.nl)"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Pieter",
                    "last_name": "Stolk",
                    "name": null,
                    "headline": "Pharma, life sciences, regulation and policy"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Antoine Juliens",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Jan Raaijmakers",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Michel Goldman",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Daan",
                    "last_name": "Crommelin",
                    "name": null,
                    "headline": "Emeritus Professor in Biopharmaceutics"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Jorg",
                    "last_name": "Janssen",
                    "name": null,
                    "headline": "Managing Director at Lygature"
                }
            ]
        }
    ],
    "courses": [
        {
            "name": "Active Listening Harthorend",
            "number": null
        },
        {
            "name": "Budget Impact Analysis: Applications and Design Issues, ISPOR Montreal",
            "number": null
        },
        {
            "name": "Decision Modeling for Health Economic Evaluation, University of Glasgow and University of York",
            "number": null
        },
        {
            "name": "Deriving robust Evidence from Real World Data: A case based workshop on study design",
            "number": null
        },
        {
            "name": "Effective Communication Lilian Nagel",
            "number": null
        },
        {
            "name": "Excel 2007 Expert course LearnIt",
            "number": null
        },
        {
            "name": "Finance, Control & Compliance management development, TSM Business School",
            "number": null
        },
        {
            "name": "First Line Leadership ",
            "number": null
        },
        {
            "name": "Health Economics B: Becoming an expert. Janssen HEMAR Academy. UMIT Professor Uwe Siebert",
            "number": null
        },
        {
            "name": "Impactfull Communication. Rik Moons",
            "number": null
        },
        {
            "name": "Impactiful Communication v2.0 (Rick Moons)",
            "number": null
        },
        {
            "name": "Introduction to Pharmacoeconomics, ISPOR Montreal",
            "number": null
        },
        {
            "name": "Minto Pyramid Principles Advante",
            "number": null
        },
        {
            "name": "Negotiations A and B by Halcyon Global Ltd.",
            "number": null
        },
        {
            "name": "Open Negotiation FPNP",
            "number": null
        },
        {
            "name": "Project Management Lindsay McKenna",
            "number": null
        },
        {
            "name": "Risk-Sharing/Performance-Based Arrangements for Drugs and Other Medical Products, ISPOR Montreal",
            "number": null
        },
        {
            "name": "SIR Pharma",
            "number": null
        },
        {
            "name": "Statistics course A. Janssen HEMAR Academy. University of Hasselt",
            "number": null
        },
        {
            "name": "Strategic Account Mgt & Co-creation with our Customers. Prof. Deva Rangarajan, Vlerick School",
            "number": null
        }
    ],
    "test_scores": [],
    "position_groups": [
        {
            "company": {
                "id": null,
                "name": "Alliance of Regenerative Medicine (ARM)",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 6,
                    "day": null,
                    "year": 2023
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "profile_positions": [
                {
                    "location": null,
                    "date": {
                        "start": {
                            "month": 6,
                            "day": null,
                            "year": 2023
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": null
                        }
                    },
                    "company": "Alliance of Regenerative Medicine (ARM)",
                    "description": "As the European Market Access and Value Advisory Group of ARM - the alliance of companies working in the field of regenerative medicines (Gene and Cell therapies) - our main objective is to optimize the European access environment for gene and cell therapies",
                    "title": "Member of Alliance of Regenerative Medicine (ARM) European Market Access and Value Advisory Group",
                    "employment_type": "Part-time"
                }
            ]
        },
        {
            "company": {
                "id": 15093145,
                "name": "Janssen Europe, Middle East & Africa (EMEA)",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQFnwjZH9RiMUQ/company-logo_400_400/0/1553550178076/janssen_europe_middle_east__africa_logo?e=1703721600&v=beta&t=rWufNwGFKIu_TToBVerT1r1onoRm8ULStCLByDTAd4c",
                "url": "https://www.linkedin.com/company/janssen-europe-middle-east-&-africa/",
                "employees": {
                    "start": 10001,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 3,
                    "day": null,
                    "year": 2021
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "profile_positions": [
                {
                    "location": "Zeist, Utrecht, Netherlands",
                    "date": {
                        "start": {
                            "month": 3,
                            "day": null,
                            "year": 2021
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": null
                        }
                    },
                    "company": "Janssen Europe, Middle East & Africa (EMEA)",
                    "description": "Responsible for developing, delivering and executing an Europe, Middle East & Africa (EMEA) Market Access strategy for multiple new (gene) therapies within the field of retina, one of the Company's flagships. \nProviding strategic market access leadership at the brand level, expertly representing the Health Economics Market Access and Reimbursement (HEMAR) function within the EMEA cross-functional team, building strong relationships and effective collaboration within the matrix. In doing so, I will shape the IBVT agenda and decision-making to ensure that strategic plans fully meet the needs of market access in key countries. I will be responsible to co-shape the global market access strategies, including integrated evidence generation plans and payer tools that meet the needs of the EMEA region. I will lead the development of regional brand value propositions and collaborate through the functional network with EMEA operating company HEMAR managers to deliver timely, optimal reimbursement in a highly challenging environment across a diverse region with complex and differing needs.",
                    "title": "Compound Market Access Leader Europe Middle East and Africa (EMEA) ",
                    "employment_type": "Full-time"
                }
            ]
        },
        {
            "company": {
                "id": 1204,
                "name": "The Janssen Pharmaceutical Companies of Johnson & Johnson",
                "logo": "https://media.licdn.com/dms/image/C4D0BAQG0V9OOxXc2sQ/company-logo_400_400/0/1519855865090?e=1703721600&v=beta&t=JjOCN9AWyvfYIaeiMjnBBZqAipgLz-UwgH9buvPguV4",
                "url": "https://www.linkedin.com/company/janssen-pharmaceutical-companies-of-johnson-and-johnson/",
                "employees": {
                    "start": 10001,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 2,
                    "day": null,
                    "year": 2014
                },
                "end": {
                    "month": 2,
                    "day": null,
                    "year": 2021
                }
            },
            "profile_positions": [
                {
                    "location": "High Wycombe",
                    "date": {
                        "start": {
                            "month": 2,
                            "day": null,
                            "year": 2018
                        },
                        "end": {
                            "month": 2,
                            "day": null,
                            "year": 2021
                        }
                    },
                    "company": "The Janssen Pharmaceutical Companies of Johnson & Johnson",
                    "description": "Responsible for organizing and/or optimizing patient access to new interventions in the field of Neurosciences and Infectious Diseases (vaccines) in the United Kingdom, including NICE and SMC submissions and integrated evidence generation.\nCross-functional UK team lead for Vaccines since Jun 2020.",
                    "title": "Senior Manager Health Economics, Market Access and Reimbursement and Team Lead Janssen UK",
                    "employment_type": "Full-time"
                },
                {
                    "location": "Breda Area, Netherlands",
                    "date": {
                        "start": {
                            "month": 10,
                            "day": null,
                            "year": 2014
                        },
                        "end": {
                            "month": 2,
                            "day": null,
                            "year": 2018
                        }
                    },
                    "company": "The Janssen Pharmaceutical Companies of Johnson & Johnson",
                    "description": "Development assignment as HEMAR (Health Economics, Market Access and Reimbursement) manager in the Neurosciences EMEA (Europe, Middle East and Africa) team from April 2017 onwards for ~50% of the time. Focus: preparing for launch of Intranasal Esketamine. \n\nMain focus areas in NL:\n- Hematology, primarily Non Hodgkin Lymphoma (From Jan 2017 onwards)\n- Oncology, primarily prostate cancer (from Sep 2015 - Jan 2017)\n- Infectious Diseases and Vaccines, primarily HIV, Hepatitis C and RSV (from Oct 2014 - Jan 2017)\n- Neurosciences, primarily schizophrenia and depressive disorders (from Oct 2014 - March 2017)\n- Real World Evidence (from 2015 onwards)\n- Companion Diagnostics (from 2017 onwards)\nEnsured reimbursement for 5 innovative drugs in 7 different indications and led various projects to increase patient access\n\nFrom August 2016 - March 2017: Development Assignment for Strategic Account Management within Hematology (Multiple Myeloma)\n\nIn addition to that, president of working group at Young Innovators of Medicines (Young Nefarma, association of all innovative pharmaceutical companies active in the Netherlands) in 2016",
                    "title": "Manager Health Economics and Market Access",
                    "employment_type": "Full-time"
                },
                {
                    "location": "Beerse (Belgium)",
                    "date": {
                        "start": {
                            "month": 2,
                            "day": null,
                            "year": 2014
                        },
                        "end": {
                            "month": 8,
                            "day": null,
                            "year": 2015
                        }
                    },
                    "company": "The Janssen Pharmaceutical Companies of Johnson & Johnson",
                    "description": "Development assignment: Supporting the Global Commercial Strategic Organization Hepatitis Team in Market Access and Health Economics projects for simeprevir and future Hepatitis C compounds\n- Set up Standing Global Payer Advisory Panel\n- Created Global HepC RWE Research Framework",
                    "title": "Global Manager Health Economics and Market Access",
                    "employment_type": "Part-time"
                },
                {
                    "location": "Tilburg Area, Netherlands",
                    "date": {
                        "start": {
                            "month": 2,
                            "day": null,
                            "year": 2014
                        },
                        "end": {
                            "month": 10,
                            "day": null,
                            "year": 2014
                        }
                    },
                    "company": "The Janssen Pharmaceutical Companies of Johnson & Johnson",
                    "description": "Development assignment: Supporting the Health Economics, Market Access & Reimbursement team to prepare for the launch of ibrutinib in the Dutch market\n- Led the selection and prioritization of projects that enhances the value proposition of ibrutinib\n- Created Easy To Use Budget Impact Models for Key Account Managers\n- Wrote notifications ibrutinib for reimbursement approval by ZiNL (HTA-body Netherlands)",
                    "title": "Manager Health Economics and Market Access",
                    "employment_type": "Part-time"
                }
            ]
        },
        {
            "company": {
                "id": 19024885,
                "name": "Young Innovators of Medicines",
                "logo": "https://media.licdn.com/dms/image/C560BAQGLytUxV5SQNw/company-logo_400_400/0/1634730272520/younginnovatorsofmedicines_logo?e=1703721600&v=beta&t=f-nNXx_uXu9X7abBGCAjbBnnm79SBxK1U-QwZ6aQ1To",
                "url": "https://www.linkedin.com/company/younginnovatorsofmedicines/",
                "employees": {
                    "start": 11,
                    "end": 50
                }
            },
            "date": {
                "start": {
                    "month": 11,
                    "day": null,
                    "year": 2016
                },
                "end": {
                    "month": 12,
                    "day": null,
                    "year": 2017
                }
            },
            "profile_positions": [
                {
                    "location": "The Hague Area, Netherlands",
                    "date": {
                        "start": {
                            "month": 11,
                            "day": null,
                            "year": 2016
                        },
                        "end": {
                            "month": 12,
                            "day": null,
                            "year": 2017
                        }
                    },
                    "company": "Young Innovators of Medicines",
                    "description": "The Young Innovators of Medicines is a department of the Dutch branch organization of innovative pharmaceutical companies (Vereniging Innovatieve Geneesmiddelen). The department is ran by a maximum of one representative per company, which totals 25+ active members. The department is led by a board of six board members. Four of the board members are chairing the four working groups that work on the topics: Partnerships, Interaction, Talent & Development, and Debate & Recommendation.\n\nMy role is to chair the board, represent the Young Innovators of Medicines at external meetings and stay connected and aligned with the board of the Dutch brand organization of innovative pharmaceutical companies. In addition to that, I led the development of a document describing the Vision of the Young Innovators  about the future developments in the Dutch healthcare market and specifically the role of pharmaceutical companies in these developments. The document is used as a guidance for discussion with a.o. the Minister of MoH.",
                    "title": "Chairman Of The Board",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 15417,
                "name": "Crucell - affiliate of Johnson and Johnson",
                "logo": "https://media.licdn.com/dms/image/C560BAQG4IkT-TRWuLQ/company-logo_400_400/0/1519855939934?e=1703721600&v=beta&t=h0i3XHAYpcyrKzEJIycoxd8QsikHxIVfBh2NG4UYxfs",
                "url": "https://www.linkedin.com/company/crucell/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 10,
                    "day": null,
                    "year": 2010
                },
                "end": {
                    "month": 10,
                    "day": null,
                    "year": 2014
                }
            },
            "profile_positions": [
                {
                    "location": "Leiden, The Netherlands",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2012
                        },
                        "end": {
                            "month": 10,
                            "day": null,
                            "year": 2014
                        }
                    },
                    "company": "Crucell",
                    "description": "- Responsible for Dukoral, Crucell's cholera vaccine (on global Net Margin)\n- Since Jan 2013, led Global Product Team Dukoral and responsible for lifecycle management projects\n- Quinvaxem marketing and forecasting\n- In 2012, Inflexal V supply negotiations and process improvements\n- Business wide projects: building business cases for e.g.,: entering new countries, participating in regional business deals (e.g., in Middle East or Latin America), clinical trials, and developing a new presentation of existing vaccines. All resulting in the creation of advices for management team.",
                    "title": "Business Manager Marketed Products",
                    "employment_type": null
                },
                {
                    "location": "The Hague Area, Netherlands",
                    "date": {
                        "start": {
                            "month": 10,
                            "day": null,
                            "year": 2010
                        },
                        "end": {
                            "month": 2,
                            "day": null,
                            "year": 2012
                        }
                    },
                    "company": "Crucell",
                    "description": "- Create and update business case model to valuate organization for a potential acquisition\n- Create and update population based forecasting model for pentavalent vaccines and specifically Quinvaxem global sales\n- Create and manage global marketing plans for Quinvaxem\n- Manage business case for pipeline product and be part of development project core team",
                    "title": "Junior Business Manager Paediatric franchise",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 10221533,
                "name": "Apotheek Koert B.V.",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQE3alV53kDLVA/company-logo_400_400/0/1519910254402?e=1703721600&v=beta&t=OxFJPLPThIX_htEjc-9Iugc8jq7NrlYk09PknlUiWAg",
                "url": "https://www.linkedin.com/company/apotheekkoert/",
                "employees": {
                    "start": 51,
                    "end": 200
                }
            },
            "date": {
                "start": {
                    "month": 8,
                    "day": null,
                    "year": 2008
                },
                "end": {
                    "month": 10,
                    "day": null,
                    "year": 2010
                }
            },
            "profile_positions": [
                {
                    "location": "Utrecht Area, Netherlands",
                    "date": {
                        "start": {
                            "month": 8,
                            "day": null,
                            "year": 2008
                        },
                        "end": {
                            "month": 10,
                            "day": null,
                            "year": 2010
                        }
                    },
                    "company": "Apotheek Koert B.V.",
                    "description": "Pharmacist in public pharmacy Koert (80-110 employees) in Utrecht, 12 hours per week and 40 hours per week during holidays. Primary tasks: patient care, giving oral information, and also inserting and checking prescriptions and checking medicine-computing-signals and if necessary follow them up. Since summer 2009 also at least 4 hours per week organizing the medicine distribution of prisoners in prison region Utrecht, in Houten.",
                    "title": "Pharmacist",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": null,
                "name": "Top Institute Pharma",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 2,
                    "day": null,
                    "year": 2010
                },
                "end": {
                    "month": 8,
                    "day": null,
                    "year": 2010
                }
            },
            "profile_positions": [
                {
                    "location": "The Hague Area, Netherlands",
                    "date": {
                        "start": {
                            "month": 2,
                            "day": null,
                            "year": 2010
                        },
                        "end": {
                            "month": 8,
                            "day": null,
                            "year": 2010
                        }
                    },
                    "company": "Top Institute Pharma",
                    "description": "Building a framework which can be used to measure their value for the parties involved in this Public-Praivate Partnership. Subsequently refining it by empirical and theorectical research.",
                    "title": "Intern Strategy & Business Development",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": null,
                "name": "Molecular Oncology Group",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 7,
                    "day": null,
                    "year": 2006
                },
                "end": {
                    "month": 1,
                    "day": null,
                    "year": 2007
                }
            },
            "profile_positions": [
                {
                    "location": "Sydney, Australia",
                    "date": {
                        "start": {
                            "month": 7,
                            "day": null,
                            "year": 2006
                        },
                        "end": {
                            "month": 1,
                            "day": null,
                            "year": 2007
                        }
                    },
                    "company": "Molecular Oncology Group",
                    "description": "Internship at Molecular Oncology Group, in the Oncology Research unit in Westmead, Sydney, Australia; Identification of domains involved in interactions between MAL2 and its binding partners, 6 months, 40 hours per week. Acquired much knowledge concerning the tasks of a researcher and learned many techniques such as cloning DNA using mould.",
                    "title": "Internship",
                    "employment_type": null
                }
            ]
        }
    ],
    "volunteer_experiences": [],
    "skills": [
        "Access Policy Shaping",
        "Access Strategy",
        "Innovative Payment Models",
        "Gene Therapy",
        "Business Strategy",
        "ATMP",
        "Integrated Evidence Generation Planning",
        "Product Marketing",
        "M&A experience",
        "Marketing Strategy",
        "Dutch",
        "Healthcare",
        "English",
        "Excel",
        "Teamwork",
        "Business Development",
        "Management",
        "Pharmaceutical Industry",
        "Market Access",
        "Clinical Trials"
    ],
    "network_info": null,
    "related_profiles": null,
    "contact_info": null
}